2,4-thiazolidinedione has been researched along with Hypertension, Pulmonary in 2 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansmann, G | 1 |
| Calvier, L | 1 |
| Risbano, MG | 1 |
| Chan, SY | 1 |
| Michaelson, J | 1 |
2 reviews available for 2,4-thiazolidinedione and Hypertension, Pulmonary
| Article | Year |
|---|---|
Activation of the Metabolic Master Regulator PPARĪ³: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension.
Topics: Animals; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Muscle, Smooth, V | 2020 |
Thiazolidinedione associated volume overload and pulmonary hypertension.
Topics: Aged; Blood Volume; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension, Pulmonar | 2008 |